Chemoinformaics analysis of Acetoxychavicol-Acetate
| Molecular Weight | 234.251 | nRot | 4 |
| Heavy Atom Molecular Weight | 220.139 | nRig | 9 |
| Exact Molecular Weight | 234.089 | nRing | 1 |
| Solubility: LogS | -2.616 | nHRing | 0 |
| Solubility: LogP | 1.874 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 34.2531 |
| nHD | 0 | BPOL | 19.2529 |
| QED | 0.456 |
| Synth | 2.745 |
| Natural Product Likeliness | 1.109 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -4.547 |
| MDCK | 0.0000293 |
| BBB | 0.989 |
| PPB | 0.718901 |
| VDSS | 0.354 |
| FU | 0.406157 |
| CYP1A2-inh | 0.239 |
| CYP1A2-sub | 0.089 |
| CYP2c19-inh | 0.397 |
| CYP2c19-sub | 0.414 |
| CYP2c9-inh | 0.253 |
| CYP2c9-sub | 0.899 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.36 |
| CYP3a4-inh | 0.143 |
| CYP3a4-sub | 0.352 |
| CL | 1.229 |
| T12 | 0.509 |
| hERG | 0.012 |
| Ames | 0.94 |
| ROA | 0.239 |
| SkinSen | 0.078 |
| Carcinogencity | 0.809 |
| EI | 0.255 |
| Respiratory | 0.914 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.567497 |